Results: 1-25 | 26-30
Results: 1-25/30

Authors: Pittet, MJ Speiser, DE Valmori, D Rimoldi, D Lienard, D Lejeune, F Cerottini, JC Romero, P
Citation: Mj. Pittet et al., Ex vivo analysis of tumor antigen specific CD8(+) T cell responses using MHC/peptide tetramers in cancer patients, INT IMMUNO, 1(7), 2001, pp. 1235-1247

Authors: Romero, P Dutoit, V Rubio-Godoy, V Lienard, D Speiser, D Guillaume, P Servis, K Rimoldi, D Cerottini, JC Valmori, D
Citation: P. Romero et al., CD8(+) T-cell response to NY-ESO-1: Relative antigenicity and in vitro immunogenicity of natural and analogue sequences, CLIN CANC R, 7(3), 2001, pp. 766S-772S

Authors: Pittet, MJ Speiser, DE Lienard, D Valmori, D Guillaume, P Dutoit, V Rimoldi, D Lejeune, F Cerottini, JC Romero, P
Citation: Mj. Pittet et al., Expansion and functional maturation of human tumor antigen-specific CD8(+)T cells after vaccination with antigenic peptide, CLIN CANC R, 7(3), 2001, pp. 796S-803S

Authors: Morillon, R Lienard, D Chrispeels, MJ Lassalles, JP
Citation: R. Morillon et al., Rapid movements of plants organs require solute-water cotransporters or contractile proteins, PLANT PHYSL, 127(3), 2001, pp. 720-723

Authors: Rubio-Godoy, V Dutoit, V Rimoldi, D Lienard, D Lejeune, F Speiser, D Guillaume, P Cerottini, JC Romero, P Valmori, D
Citation: V. Rubio-godoy et al., Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life, P NAS US, 98(18), 2001, pp. 10302-10307

Authors: Speiser, DE Colonna, M Ayyoub, M Cella, M Pittet, MJ Batard, P Valmori, D Guillaume, P Lienard, D Cerottini, JC Romero, P
Citation: De. Speiser et al., The activatory receptor 2B4 is expressed in vivo by human CD8(+) effector alpha beta T cells, J IMMUNOL, 167(11), 2001, pp. 6165-6170

Authors: Pittet, MJ Zippelius, A Speiser, DE Assenmacher, M Guillaume, P Valmori, D Lienard, D Lejeune, F Cerottini, JC Romero, P
Citation: Mj. Pittet et al., Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: Implicationsof a novel approach for T cell monitoring in infectious and malignant diseases, J IMMUNOL, 166(12), 2001, pp. 7634-7640

Authors: Ghanem, G Loir, B Morandini, R Sales, F Lienard, D Eggermont, A Lejeune, F
Citation: G. Ghanem et al., On the release and half-life of S100B protein in the peripheral blood of melanoma patients, INT J CANC, 94(4), 2001, pp. 586-590

Authors: Ayyoub, M Migliaccio, M Guillaume, P Lienard, D Cerottini, JC Romero, P Levy, F Speiser, DE Valmori, D
Citation: M. Ayyoub et al., Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cellsfrom melanoma patients reveals inefficient antigen processing., EUR J IMMUN, 31(9), 2001, pp. 2642-2651

Authors: Speiser, DE Migliaccio, M Pittet, MJ Valmori, D Lienard, D Lejeune, F Reichenbach, P Guillaume, P Luscher, I Cerottini, JC Romero, P
Citation: De. Speiser et al., Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells, EUR J IMMUN, 31(2), 2001, pp. 459-466

Authors: Dietrich, PY Walker, PR Quiquerez, AL Perrin, G Dutoit, V Lienard, D Guillaume, P Cerottini, JC Romero, P Valmori, D
Citation: Py. Dietrich et al., Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptidewith diverse and nonoverlapping T-cell receptor repertoires, CANCER RES, 61(5), 2001, pp. 2047-2054

Authors: Valmori, D Dutoit, V Rubio-Godoy, V Chambaz, C Lienard, D Guillaume, P Romero, P Cerottini, JC Rimoldi, D
Citation: D. Valmori et al., Frequent cytolytic T-cell responses to peptide IMAGE-A10(254-262) in melanoma, CANCER RES, 61(2), 2001, pp. 509-512

Authors: Dutoit, V Rubio-Godoy, V Dietrich, PY Quiqueres, AL Schnuriger, V Rimoldi, D Lienard, D Speiser, D Guillaume, P Batard, P Cerottini, JC Romero, P Valmori, D
Citation: V. Dutoit et al., Heterogeneous T-cell response to MAGE-A10(254-262): High avidity-specific cytolytic T lymphocytes show superior antitumor activity, CANCER RES, 61(15), 2001, pp. 5850-5856

Authors: Lejeune, FJ Pujol, N Lienard, D Mosimann, F Raffaoul, W Genton, A Guillou, L Landry, M Chassot, PG Chiolero, R Bischof-Delaloye, A Leyvraz, S Mirimanoff, RO Bejkos, D Leyvraz, PF
Citation: Fj. Lejeune et al., Limb salvage by neoadjuvant isolated perfusion with TNF alpha and melphalan for non-resectable soft tissue sarcoma of the extremities, EUR J SUR O, 26(7), 2000, pp. 669-678

Authors: Rimoldi, D Rubio-Godoy, V Dutoit, V Lienard, D Salvi, S Guillaume, P Speiser, D Stockert, E Spagnoli, G Servis, C Cerottini, JC Lejeune, F Romero, P Valmori, D
Citation: D. Rimoldi et al., Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma, J IMMUNOL, 165(12), 2000, pp. 7253-7261

Authors: Valmori, D Dutoit, V Lienard, D Lejeune, F Speiser, D Rimoldi, D Cerundolo, V Dietrich, PY Cerottini, JC Romero, P
Citation: D. Valmori et al., Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8(+) T cells in melanoma patients, J IMMUNOL, 165(1), 2000, pp. 533-538

Authors: Valmori, D Levy, F Miconnet, I Zajac, P Spagnoli, GC Rimoldi, D Lienard, D Cerundolo, V Cerottini, JC Romero, P
Citation: D. Valmori et al., Induction of potent antitumor CTL responses by recombinant vaccinia encoding a Melan-A peptide analogue, J IMMUNOL, 164(2), 2000, pp. 1125-1131

Authors: Valmori, D Dutoit, V Lienard, D Rimoldi, D Pittet, MJ Champagne, P Ellefsen, K Sahin, U Speiser, D Lejeune, F Cerottini, JC Romero, P
Citation: D. Valmori et al., Naturally occurring human lymphocyte antigen-A2 restricted CD8+T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients, CANCER RES, 60(16), 2000, pp. 4499-4506

Authors: Autier, P Dore, JF Negrier, S Lienard, D Panizzon, R Lejeune, FJ Guggisberg, D Eggermont, AMM
Citation: P. Autier et al., Sunscreen use and duration of sun exposure: a double-blind, randomized trial, J NAT CANC, 91(15), 1999, pp. 1304-1309

Authors: Valmori, D Fonteneau, JF Valitutti, S Gervois, N Dunbar, R Lienard, D Rimoldi, D Cerundolo, V Jotereau, F Cerottini, JC Speiser, DE Romero, P
Citation: D. Valmori et al., Optimal activation of tumor-reactive T cells by selected antigenic peptideanalogues, INT IMMUNOL, 11(12), 1999, pp. 1971-1979

Authors: Gander, M Leyvraz, S Decosterd, L Bonfanti, M Marzolini, C Shen, F Lienard, D Perey, L Colella, G Biollaz, J Lejeune, F Yarosh, D Belanich, M D'Incalci, M
Citation: M. Gander et al., Sequential administration of temozolomide and fotemustine: Depletion of O-6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours, ANN ONCOL, 10(7), 1999, pp. 831-838

Authors: Valmori, D Gervois, N Rimoldi, D Fonteneau, JF Bonelo, A Lienard, D Rivoltini, L Jotereau, F Cerottini, JC Romero, P
Citation: D. Valmori et al., Diversity of the fine specificity displayed by HLA-A0201-restricted CTL specific for the immunodominant Melan-A/MART-1. (vol 161, pg 6956, 1998), J IMMUNOL, 163(2), 1999, pp. 1093-1093

Authors: Speiser, DE Pittet, MJ Valmori, D Dunbar, R Rimoldi, D Lienard, D MacDonald, HR Cerottini, JC Cerundolo, V Romero, P
Citation: De. Speiser et al., In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes, J EXP MED, 190(6), 1999, pp. 775-782

Authors: Pittet, MJ Valmori, D Dunbar, PR Speiser, DE Lienard, D Lejeune, F Fleischhauer, K Cerundolo, V Cerottini, JC Romero, P
Citation: Mj. Pittet et al., High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals, J EXP MED, 190(5), 1999, pp. 705-715

Authors: Marchand, M van Baren, N Weynants, P Brichard, V Dreno, B Tessier, MH Rankin, E Parmiani, G Arienti, F Humblet, Y Bourlond, A Vanwijck, R Lienard, D Beauduin, M Dietrich, PY Russo, V Kerger, J Masucci, G Jager, E De Greve, J Atzpodien, J Brasseur, F Coulie, PG Van der Bruggen, P Boon, T
Citation: M. Marchand et al., Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1, INT J CANC, 80(2), 1999, pp. 219-230
Risultati: 1-25 | 26-30